Literature DB >> 31787856

Overview of Ablative Therapy for Hepatocellular Carcinoma.

Steven C Rose1.   

Abstract

Entities:  

Year:  2019        PMID： 31787856      PMCID： PMC6875874     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  14 in total

1.  Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.

Authors:  Oleg Mironov; Arash Jaberi; John R Kachura
Journal:  J Vasc Interv Radiol       Date:  2017-01-07       Impact factor: 3.464

2.  Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma.

Authors:  Ahmed Gabr; Nadine Abouchaleh; Rehan Ali; Talia Baker; Juan Caicedo; Nitin Katariya; Michael Abecassis; Ahsun Riaz; Robert J Lewandowski; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2018-09-27       Impact factor: 3.464

3.  Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection--Propensity Score Analyses of Long-term Outcomes.

Authors:  Tae Wook Kang; Jong Man Kim; Hyunchul Rhim; Min Woo Lee; Young-sun Kim; Hyo Keun Lim; Dongil Choi; Kyoung Doo Song; Choon Hyuck David Kwon; Jae-Won Joh; Seung Woon Paik; Yong Han Paik; Joong Hyun Ahn
Journal:  Radiology       Date:  2015-02-16       Impact factor: 11.105

4.  Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched Study.

Authors:  Siddharth A Padia; Guy E Johnson; Kathryn J Horton; Christopher R Ingraham; Matthew J Kogut; Sharon Kwan; Sandeep Vaidya; Wayne L Monsky; James O Park; Renuka Bhattacharya; Daniel S Hippe; William P Harris
Journal:  J Vasc Interv Radiol       Date:  2017-03-30       Impact factor: 3.464

5.  Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma.

Authors:  Robert J Lewandowski; Ahmed Gabr; Nadine Abouchaleh; Rehan Ali; Ali Al Asadi; Ronald A Mora; Laura Kulik; Daniel Ganger; Kush Desai; Bartley Thornburg; Samdeep Mouli; Ryan Hickey; Juan Carlos Caicedo; Michael Abecassis; Ahsun Riaz; Riad Salem
Journal:  Radiology       Date:  2018-04-24       Impact factor: 11.105

Review 6.  Microwave Ablation Compared to Radiofrequency Ablation for Hepatic Lesions: A Meta-Analysis.

Authors:  Ya Ruth Huo; Guy D Eslick
Journal:  J Vasc Interv Radiol       Date:  2015-05-28       Impact factor: 3.464

7.  Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.

Authors:  Yoshitaka Takuma; Hiroyuki Takabatake; Youichi Morimoto; Nobuyuki Toshikuni; Takahisa Kayahara; Yasuhiro Makino; Hiroshi Yamamoto
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

8.  Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy.

Authors:  Michael Vouche; Ali Habib; Thomas J Ward; Edward Kim; Laura Kulik; Daniel Ganger; Mary Mulcahy; Talia Baker; Michael Abecassis; Kent T Sato; Juan-Carlos Caicedo; Jonathan Fryer; Ryan Hickey; Elias Hohlastos; Robert J Lewandowski; Riad Salem
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

9.  Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.

Authors:  Siddharth A Padia; Sharon W Kwan; Bahman Roudsari; Wayne L Monsky; Andrew Coveler; William P Harris
Journal:  J Vasc Interv Radiol       Date:  2014-05-14       Impact factor: 3.464

10.  Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.

Authors:  Haruyuki Takaki; Koichiro Yamakado; Atsuhiro Nakatsuka; Hiroyuki Fuke; Kazumoto Murata; Katsuya Shiraki; Kan Takeda
Journal:  J Vasc Interv Radiol       Date:  2007-07       Impact factor: 3.464
View more
  1 in total

1.  TGF-β-MTA1-SMAD7-SMAD3-SOX4-EZH2 Signaling Axis Promotes Viability, Migration, Invasion and EMT of Hepatocellular Carcinoma Cells.

Authors:  Kangjun Zhang; Taishi Fang; Yajie Shao; Yanhui Wu
Journal:  Cancer Manag Res       Date:  2021-09-10       Impact factor: 3.989
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.